Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2007-07-31
2007-07-31
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C564S084000, C564S086000
Reexamination Certificate
active
10850312
ABSTRACT:
Compounds having the general formula I are useful for inhibiting serine protease enzymes, such as Tissue Factor VIIa, factor Xa, thrombin and kallikrein and have improved permeability properties. These compounds may be used in methods of preventing and/or treating clotting disorders
REFERENCES:
patent: 3282933 (1966-11-01), Nys et al.
patent: 5399487 (1995-03-01), Butenas et al.
patent: 5589173 (1996-12-01), O'Brien et al.
patent: 5646165 (1997-07-01), Abelman et al.
patent: 5656600 (1997-08-01), Abelman et al.
patent: 5656645 (1997-08-01), Tamura et al.
patent: 5658930 (1997-08-01), Tamura et al.
patent: 5658939 (1997-08-01), Abelman et al.
patent: 5670479 (1997-09-01), Abelman et al.
patent: 5998424 (1999-12-01), Galemmo, Jr. et al.
patent: 6020357 (2000-02-01), Pinto et al.
patent: 6034103 (2000-03-01), Buckman et al.
patent: 6034104 (2000-03-01), Klimkowski et al.
patent: 6140353 (2000-10-01), Ackermann et al.
patent: 6358960 (2002-03-01), Senokuchi et al.
patent: 6410536 (2002-06-01), Dudley et al.
patent: 6472393 (2002-10-01), Aliagas-Martin et al.
patent: 197 18 181 (1998-11-01), None
patent: 0 976 722 (2000-02-01), None
patent: 0 987 274 (2000-03-01), None
patent: WO 93/15756 (1993-08-01), None
patent: WO 94/13693 (1994-06-01), None
patent: WO 96/10022 (1996-04-01), None
patent: WO 96/16940 (1996-06-01), None
patent: WO 96/40679 (1996-12-01), None
patent: WO 97/30073 (1997-08-01), None
patent: WO 98/46591 (1998-10-01), None
patent: WO 98/46626 (1998-10-01), None
patent: WO 98/46627 (1998-10-01), None
patent: WO 98/46628 (1998-10-01), None
patent: WO 00/15658 (2000-03-01), None
patent: WO 00/41531 (2000-07-01), None
patent: WO 03/029226 (2003-04-01), None
Katakura, S. et al., “A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin”Biochem.&Biophys. Res. Comm.197:965-972 (1993).
Lam et al., “Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants”J. Med. Chem.46:4405-4418 (2003).
Lawson, J.H. et al., “A model for the tissue factor pathway to thrombin”Journal of Biological Chemistry269:23357-23366 (1994).
Renatus et al., “Structural and Functional Analyses of Benzamidine-Based Inhibitors in Complex with Trypsin: Implications for the Inhibition of Factor Xa, tPA, and Urokinase”J. Med. Chem.41:5445-5456 (1998).
Gazzard Lewis J.
Rawson Thomas E.
Genentech Inc.
Owens Amelia A.
Wang Min
LandOfFree
Acylsulfamide inhibitors of factor VIIa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylsulfamide inhibitors of factor VIIa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylsulfamide inhibitors of factor VIIa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3766959